News Conference News ACC 2026 PCSK9 Inhibitor Very Effective in High-risk Patients Without ASCVD: VESALIUS-CV Michael O'Riordan March 29, 2026
News Daily News Premature Menopause Increases Lifetime Heart Disease Risk Regardless of Race L.A. McKeown March 23, 2026
News Daily News Positive Top-line Results for Retatrutide in Diabetes: TRANSCEND-T2D-1 Caitlin E. Cox March 19, 2026
News Daily News Lp(a) and CAC Levels Independently Predict Long-term ASCVD Risk Yael L. Maxwell March 19, 2026
News Daily News Ultraprocessed Food Again Linked to Higher CVD Risk: MESA Michael O'Riordan March 17, 2026
News Daily News Lower LDL Levels, Starting Earlier in Life: New ACC/AHA Dyslipidemia Guidelines Michael O'Riordan March 13, 2026
News Daily News Healthy Lifestyle Plus GLP-1s Yields Bigger CV Reduction Than Drugs Alone Michael O'Riordan March 03, 2026
News Daily News Side Effects of Statins Might Be Overstated: CTT Collaboration Michael O'Riordan February 12, 2026
News Daily News Both Low-fat and Low-carb Diets Tied to Less Heart Disease Michael O'Riordan February 11, 2026
News Daily News Easy Exercise Prevents Mortality in Cardio-Kidney-Metabolic Syndrome Yael L. Maxwell January 12, 2026
News Daily News Weight Regained Within 18 Months of Stopping GLP-1 Drugs Michael O'Riordan January 08, 2026
News Daily News SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide Michael O'Riordan December 18, 2025
News Daily News Making Sense of Masters Athletes’ Cardiac Imaging: Expert Review Michael O'Riordan December 11, 2025
News Daily News High Adolescent BP Tied to Subclinical Disease in Middle Age Michael O'Riordan November 20, 2025
News Conference News AHA 2025 Olezarsen Cuts Triglycerides, Pancreatitis Risk in Severe Hypertriglyceridemia Michael O'Riordan November 14, 2025
News Conference News AHA 2025 Oral PCSK9 Inhibitor Enlicitide Cuts LDL Cholesterol: CORALreef Lipids Michael O'Riordan November 10, 2025
News Conference News AHA 2025 Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV Michael O'Riordan November 08, 2025